DNVYX
Price
$29.82
Change
-$0.19 (-0.63%)
Updated
Sep 20 closing price
VFIAX
Price
$527.71
Change
-$1.02 (-0.19%)
Updated
Sep 20 closing price
Ad is loading...

DNVYX vs VFIAX

Header iconDNVYX vs VFIAX Comparison
Open Charts DNVYX vs VFIAXBanner chart's image
Davis NY Venture Y
Price$29.82
Change-$0.19 (-0.63%)
VolumeN/A
CapitalizationN/A
Vanguard 500 Index Admiral
Price$527.71
Change-$1.02 (-0.19%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
DNVYX vs VFIAX Comparison Chart
Loading...
VS
DNVYX vs. VFIAX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNVYX is a Buy and VFIAX is a Buy.

FUNDAMENTALS
Fundamentals
VFIAX has more cash in the bank: 1.24T vs. DNVYX (6.65B). VFIAX pays higher dividends than DNVYX: VFIAX (1.32) vs DNVYX (0.93). DNVYX was incepted earlier than VFIAX: DNVYX (28 years) vs VFIAX (24 years). DNVYX is a more actively managed with annual turnover of: 7.00 vs. VFIAX (2.00). VFIAX has a lower initial minimum investment than DNVYX: VFIAX (3000) vs DNVYX (5000000). VFIAX annual gain was more profitable for investors over the last year : 31.72 vs. DNVYX (16.76). VFIAX return over 5 years is better than : 90.47 vs. DNVYX (8.22).
DNVYXVFIAXDNVYX / VFIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence28 years24 years-
Gain YTD8.67419.97143%
Front LoadN/AN/A-
Min. Initial Investment50000003000166,667%
Min. Initial Investment IRAN/AN/A-
Net Assets6.65B1.24T1%
Annual Yield % from dividends0.931.3270%
Returns for 1 year16.7631.7253%
Returns for 3 years-6.0930.99-20%
Returns for 5 years8.2290.479%
Returns for 10 years-20.09190.48-11%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BLBD54.491.17
+2.19%
Blue Bird Corp
MPLX44.200.07
+0.16%
Mplx LP
AIP7.45-0.08
-1.06%
Arteris
FFIN38.10-0.74
-1.91%
First Financial Bankshares
TPST1.35-0.06
-4.26%
Tempest Therapeutics